04.27.21 -- Life Sciences Investment Outlook: Deal-Making Gets Creative
04.27.21 -- Life Sciences Investment Outlook: Deal-Making Gets Creative Catching up to the paradigm shift in optimizing, scaling-up, and manufacturing plasmids is crucial for clinical to commercial program success for gene therapies and vaccines. With an increased demand for plasmids for targeted gene therapeutic delivery, partnering with a CDMO equipped with the capacity, expertise, and equipment for plasmid DNA production is critical to ensuring a stable therapeutic supply. Join Aji Bio-Pharma to learn about methodologies to ensure effective productio...
Source: pharmaceuticalonline.com